Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 6ugy.1

Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.10 Å
Oligo State
homo-dimer
Ligands
2 x NAG- NAG- BMA- MAN- NAG- GAL- MAN- FUC: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
6 x ZN: ZINC ION(Non-covalent)
2 x ACT: ACETATE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Lerch, T.F. et al., Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar. BioDrugs (2020)
Release Date
2019-11-13
Peptides
Remicade Fc: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
A

Remicade Fc

Toggle Identical (AB)

Related Entries With Identical Sequence

4cdh.1 | 5vh5.1 | 6ugw.1 | 6ugx.1